Revvity
Clara Attia is a seasoned professional in the life sciences and applied genomics sectors, currently serving as Commercial Director Europe at Revvity since May 2023, following the role of Managing Director Southern Europe at the same company. Prior to Revvity, Clara Attia held several key positions at PerkinElmer, Inc. from September 2010 to May 2023, including Managing Director France and Sales and Service Leader for Diagnostics in France and North Africa. Clara's early career featured roles at IRCM as a Research Engineer, focusing on project management and technical skills in cellular culture and immunohistochemistry, and at tebu-bio as a Technical Sales Representative, driving sales development within major pharmaceutical companies and hospitals in Paris. Clara Attia obtained education from Université Paris-Est Créteil (UPEC).
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com